Neptune Wellness Solutions Inc (NEPT)
1.11
-0.07
(-5.93%)
USD |
NASDAQ |
Oct 04, 13:31
Neptune Wellness Solutions Gross Profit Margin (Quarterly): 12.63% for June 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 12.63% |
| March 31, 2023 | -21.14% |
| December 31, 2022 | 15.40% |
| September 30, 2022 | 9.24% |
| June 30, 2022 | -17.79% |
| March 31, 2022 | -49.39% |
| December 31, 2021 | 11.28% |
| September 30, 2021 | -9.36% |
| June 30, 2021 | -23.04% |
| March 31, 2021 | -461.0% |
| December 31, 2020 | -300.8% |
| September 30, 2020 | -18.34% |
| June 30, 2020 | 28.95% |
| March 31, 2020 | -13.22% |
| December 31, 2019 | -0.42% |
| September 30, 2019 | 0.13% |
| June 30, 2019 | -16.33% |
| March 31, 2019 | 27.44% |
| December 31, 2018 | 34.08% |
| September 30, 2018 | 33.34% |
| June 30, 2018 | 28.89% |
| March 31, 2018 | 20.57% |
| December 31, 2017 | 27.55% |
| September 30, 2017 | 6.01% |
| June 30, 2017 | 37.40% |
| Date | Value |
|---|---|
| November 30, 2016 | 28.44% |
| August 31, 2016 | 22.35% |
| May 31, 2016 | 31.27% |
| February 29, 2016 | 30.87% |
| November 30, 2015 | 29.91% |
| August 31, 2015 | 15.87% |
| May 31, 2015 | -31.15% |
| February 28, 2015 | -159.5% |
| November 30, 2014 | 9.27% |
| August 31, 2014 | -149.5% |
| May 31, 2014 | 14.16% |
| February 28, 2014 | 20.22% |
| November 30, 2013 | 13.57% |
| August 31, 2013 | 12.10% |
| May 31, 2013 | 9.97% |
| February 28, 2013 | 0.11% |
| November 30, 2012 | 47.53% |
| August 31, 2012 | 37.70% |
| May 31, 2012 | 58.70% |
| February 29, 2012 | 53.63% |
| November 30, 2011 | 53.25% |
| August 31, 2011 | 51.06% |
| May 31, 2011 | 51.94% |
| February 28, 2011 | 48.56% |
| November 30, 2010 | 59.47% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-461.0%
Minimum
Mar 2021
34.08%
Maximum
Dec 2018
-41.66%
Average
-9.36%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 96.23% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 86.32% |
| Liminal Biosciences Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -778.5% |
| Return on Assets | -111.9% |
| Return on Invested Capital | -277.2% |
| Profit Margin (Quarterly) | -78.23% |
| Operating Margin (Quarterly) | -100.2% |
| Return on Net Operating Assets | -129.7% |